Literature DB >> 3079695

Effect of synthetic prostaglandin E1 analog on gastric emptying of meals in man.

J G Moore, N Alazraki, G D Clay.   

Abstract

Forty-five subjects with healed duodenal ulcer were administered either a placebo or a low-dose or high-dose regimen of misoprostol, a synthetic PGE1 analog, in a double-blind, random, parallel-group design to assess the effect of this prostaglandin compound on the gastric emptying of liquid-solid meals. A dual-radionuclide technique to measure liquid- and solid-phase gastric emptying rates of physiological meals by external gamma camera imaging was used. All subjects had a pretreatment control (baseline) evaluation, followed one week later by a treatment-influenced emptying study. The results demonstrated that misoprostol did not significantly alter gastric emptying of either liquids or solids; however, these results cannot be extrapolated to other prostaglandin compounds because of the diverse and sometimes paradoxical effects of different prostaglandins on gastric motility.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3079695     DOI: 10.1007/bf01347904

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  11 in total

1.  Variability of gastric emptying measurements in man employing standardized radiolabeled meals.

Authors:  C M Brophy; J G Moore; P E Christian; M J Egger; A T Taylor
Journal:  Dig Dis Sci       Date:  1986-08       Impact factor: 3.199

2.  Effects of a prostaglandin E1 derivative, SC-29333, and aspirin on gastric ionic fluxes and potential difference in dogs.

Authors:  D G Colton; D A Callison; E Z Dajani
Journal:  J Pharmacol Exp Ther       Date:  1979-08       Impact factor: 4.030

3.  Gastric secretory inhibition induced by three methyl analogs of prostaglandin E2 administered intragastrically to man.

Authors:  B Nylander; S Andersson
Journal:  Scand J Gastroenterol       Date:  1974-11       Impact factor: 2.423

4.  Gastric emptying of varying meal weight and composition in man. Evaluation by dual liquid- and solid-phase isotopic method.

Authors:  J G Moore; P E Christian; R E Coleman
Journal:  Dig Dis Sci       Date:  1981-01       Impact factor: 3.199

5.  Comparison of Tc-99m labeled liver and liver paté as markers for solid-phase gastric emptying.

Authors:  P E Christian; J G Moore; F L Datz
Journal:  J Nucl Med       Date:  1984-03       Impact factor: 10.057

6.  Inhibition of stimulated gastric secretion by an orally administered prostaglandin capsule. A study in normal men.

Authors:  D E Wilson; J Quertermus; M Raiser; J Curran; A Robért
Journal:  Ann Intern Med       Date:  1976-06       Impact factor: 25.391

7.  Radiation dose estimates for oral agents used in upper gastrointestinal disease.

Authors:  J A Siegel; R K Wu; L C Knight; R E Zelac; H S Stern; L S Malmud
Journal:  J Nucl Med       Date:  1983-09       Impact factor: 10.057

8.  Role of prostaglandins in regulating gastric motility.

Authors:  K M Sanders
Journal:  Am J Physiol       Date:  1984-08

9.  The cytoprotective effects of (+/-)-15-deoxy-16-alpha, beta-hydroxy-16-methyl PGE1 methyl ester (sc-29333) versus aspirin-shock gastric ulcerogenesis in the dog.

Authors:  K R Larsen; N F Jensen; E K Davis; J C Jensen; F G Moody
Journal:  Prostaglandins       Date:  1981

10.  Double-blind clinical trial on gastroduodenal ulcer healing with prostaglandin E2 analogues.

Authors:  K Gibiński; J Rybicka; E Mikoś; A Nowak
Journal:  Gut       Date:  1977-08       Impact factor: 23.059

View more
  4 in total

Review 1.  Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.

Authors:  J P Monk; S P Clissold
Journal:  Drugs       Date:  1987-01       Impact factor: 9.546

2.  Effect of misoprostol on postprandial intestinal motility and orocecal transit time in humans.

Authors:  E E Soffer; J Launspach
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

3.  Misoprostol is effective treatment for patients with severe chronic constipation.

Authors:  E E Soffer; A Metcalf; J Launspach
Journal:  Dig Dis Sci       Date:  1994-05       Impact factor: 3.199

4.  Effect of synthetic prostaglandin E1 analog (ornoprostil) on gastric emptying and pancreatic polypeptide release after solid-meal ingestion in man.

Authors:  H Okano; S Saeki; A Inui; Y Kawai; S Morimoto; A Ohmoto; T Nakashima; M Miyamoto; T Oh; A Takata
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.